The 20 Executives — and Companies — to Know in Chinese BiotechPublished: June 2020 In China, biotechnology long lagged behind the industry in the West. Now, thanks to billions of dollars in state and private investment and dramatic regulatory changes what took a half century of iteration in the U. S. has happened over the course of about 20 years in China. The results are astounding, with China now developing treatments and generics that rival the best efforts of the drug industrys incumbents. In this report, a